Jury orders Boston Scientific to pay US$432 million in stent patent dispute (Canadian Business)
Jury orders Boston Scientific to pay US$432 million in stent patent dispute (Canadian Business)
Mark Jewell, The Associated Press February 12, 2008 – 5:31 p.m. BOSTON – Boston Scientific Corp. was ordered to pay nearly US$432 million in damages to a doctor who contends the medical device maker’s drug-coated heart stents violate his 1997 patent.